DNLI
Denali Therapeutics Inc. Common StockstockNASDAQ
At CloseNov 18, 2026 3:59:59 PM EST
18.41USD+2.278%(+0.41)2,368,841
Pre-marketNov 18, 2026 9:27:30 AM EST
18.00USD0.000%(0.00)
After-hoursNov 18, 2026 4:26:30 PM EST
18.40USD-0.054%(-0.01)
DNLI Financials
In Q3 FY 2026 (ended ), Denali Therapeutics Inc. Common Stock (DNLI) reported revenue of $17.78M, net income of $70.13M, operating cash flow of −$117.44M, and assets of $1.26B (filed ).
Loading financial statements…
